Avanir Pharmaceuticals lobbies on its own behalf. For Q4 2022 it reported $40K across 1 client report and lists 1 lobbyist across its filings. Issues include Health Issues and Medicare/Medicaid.
| Client | Reported | Issues |
|---|---|---|
| AVANIR PHARMACEUTICALS | $40K | Health Issues, Medicare/Medicaid |
| Year | Reported | Clients |
|---|---|---|
| 2022 | $270K | 1 |
| 2021 | $140K | 1 |
Amounts are the filer's good-faith estimates, per report, and cannot be split by issue. See the Capitol Clarity rankings and method.